share_log

Oppenheimer Upgrades Moderna to Outperform, Announces $142 Price Target

Oppenheimer Upgrades Moderna to Outperform, Announces $142 Price Target

奧本海默將Moderna上調至跑贏大盤,宣佈目標股價142美元
Benzinga ·  01/02 07:43

Oppenheimer analyst Hartaj Singh upgrades Moderna (NASDAQ:MRNA) from Perform to Outperform and announces $142 price target.

奧本海默分析師哈塔傑·辛格將Moderna(納斯達克股票代碼:MRNA)從表現上調至跑贏大盤,並宣佈目標股價爲142美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論